Long-term Study of Epiduo in Patients With Moderate to Severe Acne

CompletedOBSERVATIONAL

Enrollment

6,036

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Acne Vulgaris

Interventions

DRUG

0.1% adapalene / 2.5% benzoyl peroxide

topical application

All Listed Sponsors

lead

Galderma Laboratorium GmbH

INDUSTRY

NCT01618773 - Long-term Study of Epiduo in Patients With Moderate to Severe Acne | Biotech Hunter | Biotech Hunter